Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
HCC1419
HER2amp
Luminal
Dactolisib
PI3K
PI3K
12001.155
uM
0.05548
0.05412
0.1725 0.0583 4.9999 0.5584
0.6612
0.5973
HCC1419
HER2amp
Luminal
Dichloroacetate
PDK
PDK
12612.176
uM
inf
inf
0.7616 0.7616 0.0000 0.2242
-0.5439
0.6422
HCC1419
HER2amp
Luminal
Disulfiram
Proteasome
Proteasome
12612.174
uM
inf
inf
0.5729 0.5729 0.0000 0.1584
0.4728
0.5962
HCC1419
HER2amp
Luminal
Docetaxel
TUBB
TUBB
7820.002
uM
inf
0.04980
0.6409 0.5965 2.2116 0.1533
0.9155
0.7084
HCC1419
HER2amp
Luminal
Docetaxel
TUBB
TUBB
10019.002
uM
0.03102
0.02212
0.3860 0.4078 4.9999 0.2530
0.9570
0.3915
HCC1419
HER2amp
Luminal
Docetaxel
TUBB
TUBB
9278.002
uM
0.01068
0.01408
-0.2346 -0.2270 1.3556 0.6466
0.9632
0.3717
HCC1419
HER2amp
Luminal
Doxorubicin
TOP2
TOP
7821.007
uM
0.48265
0.54754
-0.8299 -0.4393 4.9979 0.7531
0.7330
0.6838
HCC1419
HER2amp
Luminal
Doxorubicin
TOP2
TOP
7820.007
uM
0.42291
0.63705
-0.9817 -0.7623 2.2604 0.6431
0.9842
0.6838
HCC1419
HER2amp
Luminal
Doxorubicin
TOP2
TOP
9278.121
uM
0.46984
0.86350
-1.0000 -0.9686 1.7704 0.7017
0.9979
0.4498
HCC1419
HER2amp
Luminal
Epirubicin
TOP2
TOP
7820.017
uM
0.58010
0.98790
-0.9999 -0.7987 1.7929 0.7402
0.9646
0.6915
HCC1419
HER2amp
Luminal
Epirubicin
TOP2
TOP
9278.017
uM
0.61228
0.77480
-1.0000 -0.8536 4.2304 0.7834
0.9935
0.5453
HCC1419
HER2amp
Luminal
Epirubicin
TOP2
TOP
7821.017
uM
0.78388
0.97271
-1.0000 -0.9710 5.0000 0.7996
0.9985
0.3792
HCC1419
HER2amp
Luminal
Erlotinib
EGFR
ErbB
7440.091
uM
6.31940
8.43990
-0.3793 -0.3997 2.0302 0.2666
0.9548
0.4250
HCC1419
HER2amp
Luminal
Erlotinib
EGFR
ErbB
7437.091
uM
13.4210
14.8080
-0.3169 -0.3176 4.9998 0.1297
0.9748
0.3419
HCC1419
HER2amp
Luminal
Etoposide
TOP2
TOP
7440.074
uM
56.35720
413.51440
0.0410 -1.0000 0.5512 0.2563
0.7601
0.4778
HCC1419
HER2amp
Luminal
Etoposide
TOP2
TOP
7437.074
uM
79.41070
82.08980
-0.0892 -0.0902 4.9974 0.0631
0.9850
0.3747
HCC1419
HER2amp
Luminal
Everolimus
MTOR
MTOR
12001.164
uM
0.00326
0.01325
-0.6565 -0.4478 0.4563 0.9119
0.9257
0.4690
HCC1419
HER2amp
Luminal
Fascaplysin
CDK4
CDK
7437.084
uM
0.25725
0.39177
-1.0000 -1.0000 2.6118 0.7425
0.9852
0.4343
HCC1419
HER2amp
Luminal
FR180204
ERK1/2
MAPK
12001.166
uM
1.55430
1000.00000
0.0357 -0.7891 0.1465 0.4014
0.6135
0.5565
HCC1419
HER2amp
Luminal
FTase Inhibitor I
Ftase
MAPK
12001.167
uM
inf
inf
0.6221 0.6221 0.0000 0.3242
-0.0115
0.5287
HCC1419
HER2amp
Luminal
Gefitinib
EGFR
ErbB
9278.132
uM
7.6250
320.76430
0.2421 -1.0000 0.2938 0.2269
0.6299
0.3815
HCC1419
HER2amp
Luminal
Gefitinib
EGFR
ErbB
7820.016
uM
2.73390
5.90550
-0.9258 -1.0000 1.4265 0.4015
0.8871
0.4466
HCC1419
HER2amp
Luminal
Gefitinib
EGFR
ErbB
7818.016
uM
3.14170
9.22690
-0.6214 -1.0000 1.0197 0.2928
0.9658
0.9146
HCC1419
HER2amp
Luminal
Gefitinib
EGFR
ErbB
7821.016
uM
1.03540
2.87430
-0.9194 -1.0000 1.0760 0.3518
0.9801
0.3100
HCC1419
HER2amp
Luminal
Gefitinib
EGFR
ErbB
7819.016
uM
1.89410
5.11130
-0.8894 -1.0000 1.1067 0.2956
0.9825
0.5331